Advertisement
Solventum Corporation

Solventum Corporation (SOLV) Stock Overview

Explore Solventum Corporation’s financial performance, market position, analyst ratings, and future outlook.

SOLVNYSE
HealthcareMedical - Care Facilities
$80.94
$1.52(1.84%)
U.S. Market opens in 15h 0m
Advertisement

Solventum Corporation (SOLV)

Meyka AI Score

Z

Key Financials

Market Cap14B
P/E Ratio9.83
EPS (TTM)$8.17
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$59.72
3 Months$71.47
1 Year Target$83.39

SOLV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Solventum Corporation (SOLV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $83.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.83 and a market capitalization of 14B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.84%
5-Day Change
-2.49%
1-Month Change
10.30%
3-Month Change
19.73%
6-Month Change
-1.17%
Year-to-Date (YTD) Change
2.15%
1-Year Change
7.13%
3-Year Change
1.18%
5-Year Change
1.18%
All-Time (Max) Change
1.18%

Contact Information

651-733-1110
3M Center, Maplewood, MN, 55144

Company Facts

22,000 Employees
IPO DateApr 1, 2024
CountryUS
Actively Trading

Frequently Asked Questions